SOW
MYGN icon

State of Wyoming’s Myriad Genetics MYGN Stock Holding History

State of Wyoming’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Buy
107,783
+45,119
+72% +$205K 0.06% 289
2026
Q1 		$282K Buy
62,664
+35,922
+134% +$187K 0.03% 706
2025
Q4 		$164K Sell
26,742
-9,442
-26% -$68.5K 0.02% 1092
2025
Q3 		$262K Buy
36,184
+5,412
+18% +$32.1K 0.03% 765
2025
Q2 		$163K Buy
30,772
+22,131
+256% +$131K 0.02% 1047
2025
Q1 		$76.6K Buy
8,641
+5,143
+147% +$61.8K 0.01% 1298
2024
Q4 		$48K Sell
3,498
-397
-10% -$7.33K 0.01% 1446
2024
Q3 		$107K Buy
+3,895
New +$105K 0.02% 1079
2023
Q2 		– Sell
-1,617
Closed -$37.6K – 1705
2023
Q1 		$37.6K Buy
+1,617
New +$32.8K 0.01% 1184
2022
Q3 		– Sell
-804
Closed -$15K – 1788
2022
Q2 		$15K Buy
+804
New +$16.7K 0.01% 1544

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State of Wyoming's MYGN Position: Q2 2026 in Review

State of Wyoming increased its Myriad Genetics (MYGN) stake by 72% in Q2 2026, buying an estimated $205K and bringing the position to 107,783 shares worth $615K. The position accounts for 0.06% of the portfolio, ranked #289.

State of Wyoming first reported a position in MYGN in Q2 2022 and has held it in 10 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • State of Wyoming held 107,783 shares of Myriad Genetics worth $615K as of Q2 2026.
  • State of Wyoming bought 45,119 Myriad Genetics shares in Q2 2026, an estimated $205K.
  • Myriad Genetics made up 0.06% of State of Wyoming's portfolio in Q2 2026, its #289 holding.
  • State of Wyoming first reported a position in Myriad Genetics in Q2 2022 and has held it in 10 quarters since.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.